Böttcher H, Fischer K, Proppe D
Basic Res Cardiol. 1975 May-Jun;70(3):279-91. doi: 10.1007/BF01905511.
In experiments using spontaneously beating and electrically driven cat hearts (heart-lung preparations), the inotropic effects and therapeutic ranges of digoxin and its bis- and monodigitoxosides were compared. The myocardial contractility was measured by the maximal rate of left ventricular pressure rise, with regard to heart rate, enddiastolic left ventricular pressure, and diastolic aortic pressure. The therapeutic range was defined as the ratio of the arrhythmogenic concentration to the threshold concentration. On molar basis, an increasing cardioactivity in the order digoxin, digoxigenin-bisdigitoxoside, digoxigenin-monodigitoxoside was found. The monoditoxoside displayed the largest therapeutic range. The therapeutic range of bis-digitoxoside was similar to that of digoxin. The findings suggest that cardiac glycosides, their cardioactive derivatives and their cardioactive metabolites, respectively, do not possess identical therapeutic ranges.
在使用自发搏动和电驱动猫心脏(心肺制备物)的实验中,比较了地高辛及其双洋地黄毒糖苷和单洋地黄毒糖苷的正性肌力作用和治疗范围。通过左心室压力上升的最大速率来测量心肌收缩力,并考虑心率、舒张末期左心室压力和舒张期主动脉压力。治疗范围定义为致心律失常浓度与阈值浓度之比。以摩尔为基础,发现地高辛、洋地黄毒苷双糖苷、洋地黄毒苷单糖苷的心脏活性依次增加。单洋地黄毒糖苷的治疗范围最大。双洋地黄毒糖苷的治疗范围与地高辛相似。这些发现表明,强心苷及其具有心脏活性的衍生物和代谢产物的治疗范围并不相同。